Plexxikon
Scaffold-Based Drug Discovery
Cardio-Renal
CNS
Inflammation
Metabolic Disease
Oncology
Cardio-Renal
CNS
Inflammation
Metabolic Disease
Oncology
About
Management
Board of Directors
Scientific Advisors
Pipeline
Cardio-Renal
CNS
Inflammation
Metabolic Disease
Oncology
Clinical Trials
Partners
Partnering Opportunities
Partnerships
Investors
News
Press Releases
Plexxikon in the News
Press Kit
Careers
Contact Us
Driving Directions
07/14/2010
Plexxikon's Novel Agent Significantly Inhibits Activation of Key CNS Cells Associated With Alzheimer's Disease
06/06/2010
PLX4032 Phase 1 Extension Data in Colorectal Cancer Reported
04/20/2010
Plexxikon's PLX3397 Preclinical Data Demonstrate Potential of Novel, "First-in-Class" Cancer Drug